Replies to post #12874 on Marker Therapeutics Inc (MRKR)

[Diamondhands45]

As are all investors

[Rogerthat1]

Presenting Wednesday

TapImmune, Inc. (TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, today announced it will be a featured presenting company at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference which takes place on February 10-11, 2016 in New York City. The Company's presentation will be given on Wednesday, February 10, 2016 at 1:00 pm by Dr. John Bonfiglio, Director of TapImmune. The presentation will provide an update on clinical programs and pipeline development. TapImmune management will be available for one-on-one meetings at the conference.